Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119

PreliminaryIn VitroandIn VivoEvaluation of Antidiabetic Activity ofDucrosia anethifoliaBoiss. and Its Linear Furanocoumarins

(2014) Nagwa M. M. Shalaby et al.   Biomed Research International

High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice

(2013) Meng Zhang et al.   PLoS One

Identification and characterisation of coumarins from the roots of Angelica dahurica and their inhibitory effects against cholinesterase

(2013) Woo Duck Seo et al.   Journal of Functional Foods

Recent advances in incretin-based therapies

(2012) David Russell-Jones et al.   CLINICAL ENDOCRINOLOGY

The therapeutic potential of GPR119 agonists for type 2 diabetes

(2012) Takahide Ohishi et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

GPR119 agonists for the treatment of type 2 diabetes

(2009) Robert M Jones et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release

(2008) Zhi-Liang Chu et al.   ENDOCRINOLOGY

GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity

(2008) Matthew CT Fyfe et al.   Expert Opinion on Drug Discovery

Type 2 diabetes: new genes, new understanding

(2008) Inga Prokopenko et al.   TRENDS IN GENETICS